Abbott Laboratories (0Q15)
LSE
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 52.67B | 76.25B | 67.17B | 67.89B | 72.55B | 75.2B | 74.44B | 73.21B |
Total Current Assets | 26.78B | 20.15B | 14.63B | 15.67B | 20.44B | 24.24B | 25.22B | 22.67B |
Cash and Equivalents | 18.62B | 9.41B | 3.84B | 3.86B | 6.84B | 9.8B | 9.88B | 6.9B |
Total Non-Current Assets | 20.72B | 31.1B | 30.72B | 31.3B | 33B | 36.02B | 36.91B | 38.83B |
Total Liabilities | 31.95B | 45.15B | 36.45B | 36.59B | 39.55B | 39.17B | 37.53B | 34.39B |
Total Current Liabilities | 6.66B | 8.91B | 9.01B | 10.86B | 11.91B | 13.11B | 15.49B | 13.84B |
Total Non-Current Liabilities | 45.97B | 63.45B | 46.8B | 42.38B | 46.17B | 42.84B | 36.57B | 34.15B |
Total Equity | 20.72B | 31.1B | 30.72B | 31.3B | 33B | 36.02B | 36.91B | 38.83B |
Common Equity | 13.03B | 23.21B | 23.51B | 23.85B | 24.15B | 24.47B | 24.71B | 24.87B |
Retained Earnings | 25.57B | 23.98B | 24.56B | 25.85B | 27.63B | 31.53B | 35.26B | 37.55B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.